Haleos Labs Limited successfully completes ANVISA audit at Unit-1

Haleos Labs Limited's (Formerly known as SMS Lifesciences India Ltd) API manufacturing facility located at Sy. No. 180/2, Kazipally (V) Jinnaram MandaI, Sanga Reddy District, Telangana - 502319 (Unit -1) has been successfully inspected by the Brazilian Health Authority (ANVISA) from Sept 22, 2025 to Sept 26, 2025.

This successful Inspection reaffirms Company' compliance with International quality standards and paves the way for entry into Brazil, the largest pharmaceutical market in South America.

Shares of Haleos Labs Limited was last trading in BSE at Rs. 1145.00 as compared to the previous close of Rs. 1194.55. The total number of shares traded during the day was 107 in over 53 trades.

The stock hit an intraday high of Rs. 1181.40 and intraday low of 1145.00. The net turnover during the day was Rs. 123251.00.

Source : Equity Bulls

Keywords

HaleosLabs INE320X01016 Pharmaceuticals ANVISAAudit Unit1